<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39334706</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>Extracellular Vesicle-Enclosed Oxidative Stress- and Inflammation-Related microRNAs as Potential Biomarkers of Vitamin D Responsivity: A Pilot Study on Inflammatory Bowel Disease Patients with or without COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1047</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox13091047</ELocationID><Abstract><AbstractText>The relationship between serum 25-hydroxyvitamin D (25(OH)D) levels, genomic response to vitamin D (Vit.D), and positivity to SARS-CoV-2 remains understudied. In this pilot study, during the follow-up of patients with Inflammatory Bowel Disease (IBD) and COVID-19, we investigated this issue by analyzing the molecular contents of serum extracellular vesicles (EVs) from six groups of IBD patients (n = 32), classified according to anti-SARS-CoV-2 status, 25(OH)D level, and Vit.D supplementation, by small RNA-seq. This analysis revealed differentially expressed miRNAs, PIWI-RNA, transfer RNA, small nucleolar RNAs, and protein-coding RNAs in the EVs obtained from these cohorts of IBD patients. Experimental validation evidenced a statistically significant increase in miR30d-5p, miR150-5p, Let-7f-5p, and Let-7a-5p in the anti-SARS-CoV-2-positive and low 25(OH)D and Vit.D supplemented groups with respect to the non-Vit.D supplemented group, indicating their responsiveness to Vit.D treatment. Bioinformatics analysis highlighted the regulation of these validated miRNAs by oxidative stress and inflammation, hallmarks of IBD and COVID-19. Our study reports an unprecedented panel of circulating EV-enclosed inflammation- and oxidative stress-related miRNAs, the potentiality of which, as biomarkers for Vit.D responsivity in IBD patients, needs to be explored in future studies on larger cohorts in order to allow clinicians to optimize current treatment strategies upon viral infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ammirata</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre "Guido Tarone", University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arigoni</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre "Guido Tarone", University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licastro</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>AREA Science Park, Padriciano, 34149 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caviglia</LastName><ForeName>Gian Paolo</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0002-0529-9481</Identifier><AffiliationInfo><Affiliation>Gastroenterology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Disabato</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastroenterology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubair</LastName><ForeName>Ghania</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Mathematics "Giuseppe Peano", University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezzio</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0076-8549</Identifier><AffiliationInfo><Affiliation>IBD Centre, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saibeni</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5677-2534</Identifier><AffiliationInfo><Affiliation>Gastroenterology Unit, Rho Hospital, ASST Rhodense, 20017 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Nicolò</LastName><ForeName>Amedeo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5973-9948</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cusato</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1977-9694</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palermiti</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0860-280X</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8540-6709</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolosano</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1622-2340</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre "Guido Tarone", University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AREA Science Park, Padriciano, 34149 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Biostructure and Bioimaging, CNR, Via T. De Amicis 95, 80145 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altruda</LastName><ForeName>Fiorella</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6238-1860</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre "Guido Tarone", University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Avolio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1321-4126</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, 10149 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribaldone</LastName><ForeName>Davide Giuseppe</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0002-9421-3087</Identifier><AffiliationInfo><Affiliation>Gastroenterology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ala</LastName><ForeName>Ugo</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5408-6397</Identifier><AffiliationInfo><Affiliation>Department of Veterinary Sciences, University of Turin, Grugliasco, 10095 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagoonee</LastName><ForeName>Sharmila</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6070-6716</Identifier><AffiliationInfo><Affiliation>Institute for Biostructure and Bioimaging, CNR, Molecular Biotechnology Centre "Guido Tarone", 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FAST TRACK COVID 19</GrantID><Agency>Area Science Park and Piattaforma di Genomica del Sistema ARGO with the support of Regione Autonoma Friuli Venezia Giulia, Ministry of University and Research and Ministry of Economic development</Agency><Country /></Grant><Grant><GrantID>Ricerca Locale</GrantID><Agency>Ricerca Locale - Linea A - Department of Veterinary Sciences, University of Torino</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Crohn’s disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">inflammatory bowel diseases</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">ulcerative colitis</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334706</ArticleId><ArticleId IdType="pmc">PMC11429492</ArticleId><ArticleId IdType="doi">10.3390/antiox13091047</ArticleId><ArticleId IdType="pii">antiox13091047</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aribi M., Mennechet F.J.D., Touil-Boukoffa C. Editorial: The role of vitamin D as an immunomodulator. Front. Immunol. 2023;14:1186635. doi: 10.3389/fimmu.2023.1186635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1186635</ArticleId><ArticleId IdType="pmc">PMC10086413</ArticleId><ArticleId IdType="pubmed">37056773</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 2014;5:167. doi: 10.3389/fphys.2014.00167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00167</ArticleId><ArticleId IdType="pmc">PMC4010781</ArticleId><ArticleId IdType="pubmed">24808867</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M.J. Vitamin D and the RNA transcriptome: More than mRNA regulation. Front. Physiol. 2014;5:181. doi: 10.3389/fphys.2014.00181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00181</ArticleId><ArticleId IdType="pmc">PMC4030167</ArticleId><ArticleId IdType="pubmed">24860511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenc K., Sokal-Dembowska A., Helma K., Motyka E., Jarmakiewicz-Czaja S., Filip R. Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics. Int. J. Mol. Sci. 2024;25:1228. doi: 10.3390/ijms25021228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25021228</ArticleId><ArticleId IdType="pmc">PMC10816208</ArticleId><ArticleId IdType="pubmed">38279228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Mei L., Hao Y., Xu Y., Yang Q., Dai Z., Yang Y., Wu Z., Ji Y. Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases. Nutrients. 2024;16:2352. doi: 10.3390/nu16142352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16142352</ArticleId><ArticleId IdType="pmc">PMC11279818</ArticleId><ArticleId IdType="pubmed">39064795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S.M., Shin E.A. Exploring vitamin D metabolism and function in cancer. Exp. Mol. Med. 2018;50:1–14. doi: 10.1038/s12276-018-0038-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-018-0038-9</ArticleId><ArticleId IdType="pmc">PMC5938036</ArticleId><ArticleId IdType="pubmed">29657326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendik I., Friedel A., Roos F.F., Weber P., Eggersdorfer M. Vitamin D: A critical and essential micronutrient for human health. Front. Physiol. 2014;5:248. doi: 10.3389/fphys.2014.00248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00248</ArticleId><ArticleId IdType="pmc">PMC4092358</ArticleId><ArticleId IdType="pubmed">25071593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao T., Kikuta J., Ishii M. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules. 2021;11:1624. doi: 10.3390/biom11111624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11111624</ArticleId><ArticleId IdType="pmc">PMC8615708</ArticleId><ArticleId IdType="pubmed">34827621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Eltriki M., Hopefl R., Wright J.M., Deb S. Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies. J. Am. Nutr. Assoc. 2022;41:679–689. doi: 10.1080/07315724.2021.1951891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2021.1951891</ArticleId><ArticleId IdType="pmc">PMC8425440</ArticleId><ArticleId IdType="pubmed">34464543</ArticleId></ArticleIdList></Reference><Reference><Citation>De Nicolò A., Cusato J., Bezzio C., Saibeni S., Vernero M., Disabato M., Caviglia G.P., Ianniello A., Manca A., D’Avolio A., et al. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease. Nutrients. 2022;15:169. doi: 10.3390/nu15010169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15010169</ArticleId><ArticleId IdType="pmc">PMC9824626</ArticleId><ArticleId IdType="pubmed">36615826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pini S., Scaparrotta G., DI Vico V., Fragasso A., Stefanelli L.F., Nalesso F., Calò L.A. Vitamin D intoxication induced severe hypercalcemia from self-medication for COVID-19 infection: A public health problem? Minerva Endocrinol. 2022;47:371–374. doi: 10.23736/S2724-6507.22.03795-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-6507.22.03795-2</ArticleId><ArticleId IdType="pubmed">35775886</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini M.A., Karimi J., Talebi S.S., Piri H. The Association of COVID-19 and Reactive Oxygen Species Modulator 1 (ROMO1) with Oxidative Stress. Chonnam Med. J. 2022;58:1–5. doi: 10.4068/cmj.2022.58.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.4068/cmj.2022.58.1.1</ArticleId><ArticleId IdType="pmc">PMC8813649</ArticleId><ArticleId IdType="pubmed">35169552</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyrin-Biroulet L., Sandborn W.J., Panaccione R., Domènech E., Pouillon L., Siegmund B., Danese S., Ghosh S. Tumour necrosis factor inhibitors in inflammatory bowel disease: The story continues. Ther. Adv. Gastroenterol. 2021;14:17562848211059954. doi: 10.1177/17562848211059954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848211059954</ArticleId><ArticleId IdType="pmc">PMC8669878</ArticleId><ArticleId IdType="pubmed">34917173</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurindo L.F., Santos A.R.O.D., Carvalho A.C.A., Bechara M.D., Guiguer E.L., Goulart R.A., Vargas Sinatora R., Araújo A.C., Barbalho S.M. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites. 2023;13:96. doi: 10.3390/metabo13010096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13010096</ArticleId><ArticleId IdType="pmc">PMC9862976</ArticleId><ArticleId IdType="pubmed">36677021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Peng P., Ding N., Jia W., Huang C., Tang Y. Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease? Antioxidants. 2023;12:967. doi: 10.3390/antiox12040967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12040967</ArticleId><ArticleId IdType="pmc">PMC10135842</ArticleId><ArticleId IdType="pubmed">37107341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Zhang Z., Luo M., Zhou L., Nice E.C., Zhang W., Wang C., Huang C. Redox signaling at the crossroads of human health and disease. MedComm. 2022;3:e127. doi: 10.1002/mco2.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.127</ArticleId><ArticleId IdType="pmc">PMC8971743</ArticleId><ArticleId IdType="pubmed">35386842</ArticleId></ArticleIdList></Reference><Reference><Citation>Nousis L., Kanavaros P., Barbouti A. Oxidative Stress-Induced Cellular Senescence: Is Labile Iron the Connecting Link? Antioxidants. 2023;12:1250. doi: 10.3390/antiox12061250.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12061250</ArticleId><ArticleId IdType="pmc">PMC10295026</ArticleId><ArticleId IdType="pubmed">37371980</ArticleId></ArticleIdList></Reference><Reference><Citation>Valvano M., Magistroni M., Mancusi A., D’Ascenzo D., Longo S., Stefanelli G., Vernia F., Viscido A., Necozione S., Latella G. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics. Nutrients. 2021;13:323. doi: 10.3390/nu13020323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020323</ArticleId><ArticleId IdType="pmc">PMC7910959</ArticleId><ArticleId IdType="pubmed">33499406</ArticleId></ArticleIdList></Reference><Reference><Citation>Valvano M., Magistroni M., Cesaro N., Carlino G., Monaco S., Fabiani S., Vinci A., Vernia F., Viscido A., Latella G. Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis. Inflamm. Bowel Dis. 2024;30:281–291. doi: 10.1093/ibd/izac253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izac253</ArticleId><ArticleId IdType="pubmed">36579768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashash J.G., Elkins J., Lewis J.D., Binion D.G. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review. Gastroenterology. 2024;166:521–532. doi: 10.1053/j.gastro.2023.11.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2023.11.303</ArticleId><ArticleId IdType="pubmed">38276922</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias J.N., Lima V.M., Nutels G.S., Laurindo L.F., Barbalho S.M., de Alvares Goulart R., Araújo A.C., Suzuki R.B., Guiguer E.L. The use of vitamin D for patients with inflammatory bowel diseases. Int. J. Vitam. Nutr. Res. 2024;94:54–70. doi: 10.1024/0300-9831/a000764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0300-9831/a000764</ArticleId><ArticleId IdType="pubmed">36017738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro A., Saccu G., Mattivi S., Gaido A., Herrera Sanchez M.B., Haque S., Silengo L., Altruda F., Durazzo M., Fagoonee S. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules. 2024;14:277. doi: 10.3390/biom14030277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14030277</ArticleId><ArticleId IdType="pmc">PMC10967855</ArticleId><ArticleId IdType="pubmed">38540698</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagoonee S., Arigoni M., Manco M., Olivero M., Bizzaro F., Magagnotti C., Andolfo A., Miniscalco B., Forni M., Todeschi S., et al. Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice. Antioxid. Redox Signal. 2022;36:480–504. doi: 10.1089/ars.2021.0023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0023</ArticleId><ArticleId IdType="pmc">PMC8978575</ArticleId><ArticleId IdType="pubmed">34779230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Ou Q., Kou X. Extracellular vesicles and their indispensable roles in pathogenesis and treatment of inflammatory bowel disease: A comprehensive review. Life Sci. 2023;327:121830. doi: 10.1016/j.lfs.2023.121830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2023.121830</ArticleId><ArticleId IdType="pubmed">37286163</ArticleId></ArticleIdList></Reference><Reference><Citation>Aharon A., Dangot A., Kinaani F., Zavaro M., Bannon L., Bar-Lev T., Keren-Politansky A., Avivi I., Jacob G. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. Int. J. Mol. Sci. 2023;24:5918. doi: 10.3390/ijms24065918.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065918</ArticleId><ArticleId IdType="pmc">PMC10054500</ArticleId><ArticleId IdType="pubmed">36982991</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Bravo M.J., Wahlund C.J., Qazi K.R., Moulder R., Lukic A., Rådmark O., Lahesmaa R., Grunewald J., Eklund A., Gabrielsson S. Pulmonary sarcoidosis is associated with exosomal vitamin D-binding protein and inflammatory molecules. J. Allergy Clin. Immunol. 2017;139:1186–1194. doi: 10.1016/j.jaci.2016.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.05.051</ArticleId><ArticleId IdType="pubmed">27566455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Li L., Kong Y., Xu D., Bao Y., Zhang Z., Liao Z., Jiao J., Fan D., Long X., et al. Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder. Genes. Dis. 2024;11:1009–1021. doi: 10.1016/j.gendis.2023.02.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2023.02.049</ArticleId><ArticleId IdType="pmc">PMC10491883</ArticleId><ArticleId IdType="pubmed">37692510</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernia F., Valvano M., Longo S., Cesaro N., Viscido A., Latella G. Vitamin D in Inflammatory Bowel Diseases. Mech. Action. Ther. Implications. Nutr. 2022;14:269. doi: 10.3390/nu14020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020269</ArticleId><ArticleId IdType="pmc">PMC8779654</ArticleId><ArticleId IdType="pubmed">35057450</ArticleId></ArticleIdList></Reference><Reference><Citation>Trentini M., Zanotti F., Tiengo E., Camponogara F., Degasperi M., Licastro D., Lovatti L., Zavan B. An Apple a Day Keeps the Doctor Away: Potential Role of miRNA 146 on Macrophages Treated with Exosomes Derived from Apples. Biomedicines. 2022;10:415. doi: 10.3390/biomedicines10020415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020415</ArticleId><ArticleId IdType="pmc">PMC8962404</ArticleId><ArticleId IdType="pubmed">35203624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Z., Cui Q., Wang J., Zhou Y. TransmiR v2.0: An updated transcription factor-microRNA regulation database. Nucleic Acids Res. 2019;47:D253–D258. doi: 10.1093/nar/gky1023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1023</ArticleId><ArticleId IdType="pmc">PMC6323981</ArticleId><ArticleId IdType="pubmed">30371815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis S.A., Doratt B., Sureshchandra S., Pan T., Gonzales S.W., Shen W., Grant K.A., Messaoudi I. Profiling of extracellular vesicle-bound miRNA to identify candidate biomarkers of chronic alcohol drinking in nonhuman primates. Alcohol. Clin. Exp. Res. 2022;46:221–231. doi: 10.1111/acer.14760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.14760</ArticleId><ArticleId IdType="pmc">PMC8858875</ArticleId><ArticleId IdType="pubmed">34910314</ArticleId></ArticleIdList></Reference><Reference><Citation>Babuta M., Szabo G. Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases. J. Leukoc. Biol. 2022;111:75–92. doi: 10.1002/JLB.3MIR0321-156R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MIR0321-156R</ArticleId><ArticleId IdType="pmc">PMC9235439</ArticleId><ArticleId IdType="pubmed">34755380</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones G. Metabolism and biomarkers of vitamin D. Scand. J. Clin. Lab. Investig. Suppl. 2012;243:7–13. doi: 10.3109/00365513.2012.681892.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2012.681892</ArticleId><ArticleId IdType="pubmed">22536757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaffney-Stomberg E., Lutz L.J., Shcherbina A., Ricke D.O., Petrovick M., Cropper T.L., Cable S.J., McClung J.P. Association Between Single Gene Polymorphisms and Bone Biomarkers and Response to Calcium and Vitamin D Supplementation in Young Adults Undergoing Military Training. J. Bone Min. Res. 2017;32:498–507. doi: 10.1002/jbmr.3008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3008</ArticleId><ArticleId IdType="pubmed">27683185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui A., Zhang T., Xiao P., Fan Z., Wang H., Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front. Nutr. 2023;10:1070808. doi: 10.3389/fnut.2023.1070808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1070808</ArticleId><ArticleId IdType="pmc">PMC10064807</ArticleId><ArticleId IdType="pubmed">37006940</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C., Seuter S., de Mello V.D., Schwab U., Voutilainen S., Pulkki K., Nurmi T., Virtanen J., Tuomainen T.P., Uusitupa M. Primary vitamin D target genes allow a categorization of possible benefits of vitamin D3 supplementation. PLoS ONE. 2013;8:e71042. doi: 10.1371/journal.pone.0071042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071042</ArticleId><ArticleId IdType="pmc">PMC3726591</ArticleId><ArticleId IdType="pubmed">23923049</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukić M., Neme A., Seuter S., Saksa N., de Mello V.D., Nurmi T., Uusitupa M., Tuomainen T.P., Virtanen J.K., Carlberg C. Relevance of vitamin D receptor target genes for monitoring the vitamin D responsiveness of primary human cells. PLoS ONE. 2015;10:e0124339. doi: 10.1371/journal.pone.0124339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124339</ArticleId><ArticleId IdType="pmc">PMC4395145</ArticleId><ArticleId IdType="pubmed">25875760</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C., Raczyk M., Zawrotna N. Vitamin D: A master example of nutrigenomics. Redox Biol. 2023;62:102695. doi: 10.1016/j.redox.2023.102695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2023.102695</ArticleId><ArticleId IdType="pmc">PMC10119805</ArticleId><ArticleId IdType="pubmed">37043983</ArticleId></ArticleIdList></Reference><Reference><Citation>Giangreco A.A., Nonn L. The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J. Steroid Biochem. Mol. Biol. 2013;136:86–93. doi: 10.1016/j.jsbmb.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2013.01.001</ArticleId><ArticleId IdType="pmc">PMC3686905</ArticleId><ArticleId IdType="pubmed">23333596</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorde R., Svartberg J., Joakimsen R.M., Coucheron D.H. Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res. Notes. 2012;5:245. doi: 10.1186/1756-0500-5-245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-5-245</ArticleId><ArticleId IdType="pmc">PMC3414768</ArticleId><ArticleId IdType="pubmed">22594500</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini C., Ballan R., Herkenhoff M.E., Saad S.M.I., Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int. J. Mol. Sci. 2020;22:362. doi: 10.3390/ijms22010362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010362</ArticleId><ArticleId IdType="pmc">PMC7795229</ArticleId><ArticleId IdType="pubmed">33396382</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva E., Ananiev J., Yovchev Y., Arabadzhiev G., Abrashev H., Abrasheva D., Atanasov V., Kostandieva R., Mitev M., Petkova-Parlapanska K., et al. COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int. J. Mol. Sci. 2023;24:14876. doi: 10.3390/ijms241914876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914876</ArticleId><ArticleId IdType="pmc">PMC10573237</ArticleId><ArticleId IdType="pubmed">37834324</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirkhizi F., Ghoreishy S.M., Baker E., Hamedi-Shahraki S., Asghari S. The association of vitamin D status with oxidative stress biomarkers and matrix metalloproteinases in patients with knee osteoarthritis. Front. Nutr. 2023;10:1101516. doi: 10.3389/fnut.2023.1101516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1101516</ArticleId><ArticleId IdType="pmc">PMC9944738</ArticleId><ArticleId IdType="pubmed">36845046</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthalagu N., Murphy D.J. Is oxidative stress MYC’s Achilles heel? Cell Death Differ. 2018;25:1189–1190. doi: 10.1038/s41418-018-0117-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0117-4</ArticleId><ArticleId IdType="pmc">PMC6030217</ArticleId><ArticleId IdType="pubmed">29844569</ArticleId></ArticleIdList></Reference><Reference><Citation>Priya Dharshini L.C., Vishnupriya S., Sakthivel K.M., Rasmi R.R. Oxidative stress responsive transcription factors in cellular signalling transduction mechanisms. Cell Signal. 2020;72:109670. doi: 10.1016/j.cellsig.2020.109670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109670</ArticleId><ArticleId IdType="pubmed">32418887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaradia E., Tancini B., Emiliani C., Delo F., Pellegrino R.M., Tognoloni A., Urbanelli L., Buratta S. Extracellular Vesicles under Oxidative Stress Conditions: Biological Properties and Physiological Roles. Cells. 2021;10:1763. doi: 10.3390/cells10071763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071763</ArticleId><ArticleId IdType="pmc">PMC8306565</ArticleId><ArticleId IdType="pubmed">34359933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian Z., Li L., Cui J., Zhang H., Liu Y., Zhang C.Y., Zen K. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J. Pathol. 2011;225:544–553. doi: 10.1002/path.2907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2907</ArticleId><ArticleId IdType="pubmed">21590770</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Qi W., Shi Y. miR-150-5p inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by targeting VDR. Exp. Ther. Med. 2022;23:283. doi: 10.3892/etm.2022.11213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11213</ArticleId><ArticleId IdType="pmc">PMC8908459</ArticleId><ArticleId IdType="pubmed">35317439</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckett E.L., Martin C., Duesing K., Jones P., Furst J., Yates Z., Veysey M., Lucock M. Vitamin D Receptor Genotype Modulates the Correlation between Vitamin D and Circulating Levels of let-7a/b and Vitamin D Intake in an Elderly Cohort. J. Nutr. Nutr. 2014;7:264–273. doi: 10.1159/000381676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381676</ArticleId><ArticleId IdType="pubmed">25969372</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Liu C., Chen Z., Wang L., Li C., Zhao J., Yu Y., Zhang P., Chen W., Jiang A. 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells. Gene. 2013;522:142–146. doi: 10.1016/j.gene.2013.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.03.065</ArticleId><ArticleId IdType="pubmed">23566834</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama M., Sjögren R.J., Egan B., Krook A. miRNA let-7 expression is regulated by glucose and TNF-α by a remote upstream promoter. Biochem. J. 2015;472:147–156. doi: 10.1042/BJ20150224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20150224</ArticleId><ArticleId IdType="pubmed">26378151</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechota-Polanczyk A., Fichna J. Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedebergs Arch. Pharmacol. 2014;387:605–620. doi: 10.1007/s00210-014-0985-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-014-0985-1</ArticleId><ArticleId IdType="pmc">PMC4065336</ArticleId><ArticleId IdType="pubmed">24798211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Wang S., Zuo A., Zhang J., Wen W., Jiang W., Chen H., Liang D., Sun J., Wang M. HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol. Biol. Lett. 2021;26:40. doi: 10.1186/s11658-021-00283-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-021-00283-8</ArticleId><ArticleId IdType="pmc">PMC8414688</ArticleId><ArticleId IdType="pubmed">34479471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Zamorano J., Tomé-Carneiro J., Lopez de Las Hazas M.C., Del Pozo-Acebo L., Crespo M.C., Gómez-Coronado D., Chapado L.A., Herrera E., Latasa M.J., Ruiz-Roso M.B., et al. Intestinal miRNAs regulated in response to dietary lipids. Sci. Rep. 2020;10:18921. doi: 10.1038/s41598-020-75751-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75751-w</ArticleId><ArticleId IdType="pmc">PMC7642330</ArticleId><ArticleId IdType="pubmed">33144601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoyama K., Ohsaka F. Role of microRNAs in the crosstalk between the gut microbiota and intestinal immune system. Biosci. Microbiota Food Health. 2023;42:222–228. doi: 10.12938/bmfh.2023-027.</Citation><ArticleIdList><ArticleId IdType="doi">10.12938/bmfh.2023-027</ArticleId><ArticleId IdType="pmc">PMC10542430</ArticleId><ArticleId IdType="pubmed">37791343</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao M., Yang S., Zhou A., Li T., Liu J., Chen Y., Luo Y., Qian C., Yang F., Tang B., et al. MiR-27a-3p and miR-30b-5p inhibited-vitamin D receptor involved in the progression of tuberculosis. Front. Microbiol. 2022;13:1020542. doi: 10.3389/fmicb.2022.1020542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1020542</ArticleId><ArticleId IdType="pmc">PMC9593098</ArticleId><ArticleId IdType="pubmed">36304947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarani R., Shojaeian A., Palasca O., Doncheva N.T., Jensen L.J., Gorodkin J., Pociot F. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Front. Immunol. 2022;13:865777. doi: 10.3389/fimmu.2022.865777.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.865777</ArticleId><ArticleId IdType="pmc">PMC9208551</ArticleId><ArticleId IdType="pubmed">35734163</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Ji L.J., Feng K.D., Huang H., Liang M.R., Cheng S.J., Meng X.D. Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome. World J. Gastroenterol. 2024;30:527–541. doi: 10.3748/wjg.v30.i6.527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v30.i6.527</ArticleId><ArticleId IdType="pmc">PMC10921143</ArticleId><ArticleId IdType="pubmed">38463022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocansey D.K.W., Zhang L., Wang Y., Yan Y., Qian H., Zhang X., Xu W., Mao F. Exosome-mediated effects and applications in inflammatory bowel disease. Biol. Rev. Camb. Philos. Soc. 2020;95:1287–1307. doi: 10.1111/brv.12608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12608</ArticleId><ArticleId IdType="pmc">PMC7540363</ArticleId><ArticleId IdType="pubmed">32410383</ArticleId></ArticleIdList></Reference><Reference><Citation>Altaf-Ul-Amin M., Karim M.B., Hu P., Ono N., Kanaya S. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach. BMC Med. Genom. 2020;13:10. doi: 10.1186/s12920-020-0660-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-020-0660-y</ArticleId><ArticleId IdType="pmc">PMC7038528</ArticleId><ArticleId IdType="pubmed">32093721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightbody R.J., Taylor J.M.W., Dempsie Y., Graham A. Induction of microRNA hsa-let-7d-5p, and repression of HMGA2, contribute protection against lipid accumulation in macrophage ‘foam’ cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2021;1866:159005. doi: 10.1016/j.bbalip.2021.159005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2021.159005</ArticleId><ArticleId IdType="pubmed">34274506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S.S., Wang X.Y., Yang X.K., Liu Y.C., Fu Z.Y., Zhang L.Z., Wang Z.X., Ni J., Shuai Z.W., Pan H.F. COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal. J. Med. Virol. 2022;94:5640–5652. doi: 10.1002/jmv.28067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28067</ArticleId><ArticleId IdType="pmc">PMC9538900</ArticleId><ArticleId IdType="pubmed">35971954</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa A., Scaldaferri F., Covino M., Tursi A., Furfaro F., Mocci G., Lopetuso L.R., Maconi G., Bibbò S., Fiorani M., et al. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines. 2022;10:843. doi: 10.3390/biomedicines10040843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040843</ArticleId><ArticleId IdType="pmc">PMC9029341</ArticleId><ArticleId IdType="pubmed">35453593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gain C., Song S., Angtuaco T., Satta S., Kelesidis T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front. Microbiol. 2022;13:1111930. doi: 10.3389/fmicb.2022.1111930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1111930</ArticleId><ArticleId IdType="pmc">PMC9880066</ArticleId><ArticleId IdType="pubmed">36713204</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Frara S., Nannipieri F., Cotellessa A., Locatelli M., Rovere Querini P., Giustina A. Low Vitamin D Levels Are Associated with Long COVID Syndrome in COVID-19 Survivors. J. Clin. Endocrinol. Metab. 2023;108:e1106–e1116. doi: 10.1210/clinem/dgad207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>